Banugon, Jeron Rey A.
HRN: 19-39-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2024
MUPIROCIN 2%, 15G (TUBE)
08/25/2024
09/07/2024
TOPICAL
Pea-sized
TID
IV Site Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes